SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-03-10 23:15
Tx date 2024-03-04
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+2,222 vol
10,801
Filed 2024-03-10 23:11
Tx date 2024-03-04
$XRTX
XORTX Therapeutics Inc.
May, Charlotte Mary-Anne
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+3,333 vol
7,920
Filed 2024-03-10 23:09
Tx date 2024-03-04
$XRTX
XORTX Therapeutics Inc.
Fairbairn, James Neville
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+3,333 vol
5,699
Filed 2024-03-10 23:07
Tx date 2024-03-04
$XRTX
XORTX Therapeutics Inc.
Pratt, Raymond
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+2,222 vol
8,888
Filed 2024-03-10 23:05
Tx date 2024-03-04
$XRTX
XORTX Therapeutics Inc.
Haworth, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+3,333 vol
9,032
Filed 2024-03-10 23:04
Tx date 2024-03-04
$XRTX
XORTX Therapeutics Inc.
Farley, William James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+2,222 vol
9,443
Filed 2024-03-10 23:01
Tx date 2024-03-04
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+6,666 vol
24,155
Filed 2024-03-08 17:24
Tx date 2024-03-08
$XRTX
XORTX Therapeutics Inc.
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,091
+1,525 vol
$4.65 each
9,625
Filed 2024-03-07 15:17
Tx date 2024-03-04
$XRTX
XORTX Therapeutics Inc.
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$12,699
+2,822 vol
$4.50 each
19,488
Filed 2024-02-20 23:12
Tx date 2024-02-15
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus

+10,000 vol
10,946
Filed 2024-02-20 23:10
Tx date 2024-02-15
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$30,000
+10,000 vol
$3.00 each
67,957
Filed 2024-01-02 12:58
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-133,334 vol
16,666
Filed 2023-12-28 15:26
Tx date 2023-12-27
$XRTX
XORTX Therapeutics Inc.
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,737
+600 vol
$2.90 each
8,100
Filed 2023-12-15 11:24
Tx date 2023-12-13
$XRTX
XORTX Therapeutics Inc.
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$25,665
+7,500 vol
$3.42 each
7,500
Filed 2023-12-15 11:21
Tx date 2022-06-03
$XRTX
XORTX Therapeutics Inc.
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-12-14 23:19
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation

-7,571 vol
946
Filed 2023-12-14 22:58
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Fairbairn, James Neville
5 - Senior Officer of Issuer
Holder: 1282803 Ontario Inc. (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-42,160 vol
5,270
Filed 2023-12-14 22:57
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Fairbairn, James Neville
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-13,408 vol
1,676
Filed 2023-12-14 22:55
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Fairbairn, James Neville
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-18,928 vol
2,366
Filed 2023-12-14 22:53
Tx date 2023-11-05
$XRTX
XORTX Therapeutics Inc.
Fairbairn, James Neville
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-21,294 vol
21,294
Filed 2023-12-14 22:52
Tx date 2023-06-29
$XRTX
XORTX Therapeutics Inc.
Fairbairn, James Neville
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
42,588
Filed 2023-12-14 22:48
Tx date 2023-06-29
$XRTX
XORTX Therapeutics Inc.
Fairbairn, James Neville
5 - Senior Officer of Issuer
Holder: 1282803 Ontario Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
47,430
Filed 2023-12-14 22:48
Tx date 2023-06-29
$XRTX
XORTX Therapeutics Inc.
Fairbairn, James Neville
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
15,084
Filed 2023-12-14 22:39
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Pratt, Raymond
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-26,667 vol
6,666
Filed 2023-12-14 22:38
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Pratt, Raymond
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-26,667 vol
33,333
Filed 2023-12-14 22:34
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Haworth, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-17,778 vol
5,699
Filed 2023-12-14 22:34
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Haworth, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-8,889 vol
23,477
Filed 2023-12-14 22:32
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Haworth, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-18,928 vol
32,366
Filed 2023-12-14 22:28
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Farley, William James
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-26,667 vol
7,221
Filed 2023-12-14 22:27
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Farley, William James
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-12,184 vol
33,888
Filed 2023-12-14 22:26
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Farley, William James
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-18,928 vol
46,072
Filed 2023-12-14 21:24
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-56,883 vol
7,110
Filed 2023-12-14 21:23
Tx date 2023-03-19
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-12,776 vol
77,224
Filed 2023-12-14 21:20
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-26,667 vol
8,579
Filed 2023-12-14 21:19
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-19,264 vol
35,246
Filed 2023-12-14 21:18
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-22,714 vol
54,510
Filed 2023-12-14 17:57
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
May, Charlotte Mary-Anne
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-4,445 vol
26,438
Filed 2023-12-14 17:56
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
May, Charlotte Mary-Anne
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-18,928 vol
30,883
Filed 2023-12-14 17:21
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
May, Charlotte Mary-Anne
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-13,334 vol
13,104
Filed 2023-12-14 17:12
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
May, Charlotte Mary-Anne
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-4,445 vol
Filed 2023-12-14 17:11
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
May, Charlotte Mary-Anne
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-18,928 vol
Filed 2023-12-14 16:47
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-84,287 vol
17,489
Filed 2023-12-14 16:46
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-17,778 vol
101,776
Filed 2023-12-14 16:44
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-37,857 vol
119,554
Filed 2023-12-14 15:26
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-415,660 vol
51,957
Filed 2023-12-13 15:58
Tx date 2023-12-13
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,589
+3,000 vol
$2.53 each
473,617
Filed 2023-12-01 11:10
Tx date 2023-12-01
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,502
+2,600 vol
$3.27 each
470,617
Filed 2023-12-01 11:07
Tx date 2023-12-01
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,306
+400 vol
$3.27 each
468,017
Filed 2023-05-17 08:43
Tx date 2023-03-19
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-42,589 vol
157,411
Filed 2023-04-14 11:33
Tx date 2023-04-13
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,410
+1,500 vol
$0.94 each
467,617
Filed 2023-04-10 12:31
Tx date 2023-03-31
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,320
+2,000 vol
$0.66 each
466,117
Filed 2023-04-10 12:30
Tx date 2023-03-31
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,164
+1,800 vol
$0.65 each
464,117
Filed 2023-03-27 15:49
Tx date 2023-03-27
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,320
+2,000 vol
$0.66 each
462,317
Filed 2023-03-27 15:48
Tx date 2023-03-27
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,164
+1,800 vol
$0.65 each
460,317
Filed 2023-03-24 12:46
Tx date 2023-03-22
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,267
+1,800 vol
$0.70 each
458,517
Filed 2023-03-24 12:44
Tx date 2023-03-22
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,278
+1,800 vol
$0.71 each
456,717
Filed 2023-03-24 12:44
Tx date 2023-03-22
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,775
+2,500 vol
$0.71 each
454,917
Filed 2023-02-10 19:22
Tx date 2023-02-10
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$840.00
+1,000 vol
$0.84 each
452,417
Filed 2023-02-03 13:00
Tx date 2023-02-02
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$860.00
+1,000 vol
$0.86 each
451,417
Filed 2023-02-03 12:59
Tx date 2023-02-02
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$860.00
+1,000 vol
$0.86 each
450,417
Filed 2023-02-03 12:59
Tx date 2023-02-02
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$870.00
+1,000 vol
$0.87 each
449,417
Filed 2022-11-29 23:12
Tx date 2022-11-25
$XRTX
XORTX Therapeutics Inc.
May, Charlotte Mary-Anne
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+15,000 vol
49,811
Filed 2022-11-29 23:08
Tx date 2022-11-25
$XRTX
XORTX Therapeutics Inc.
Haworth, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
51,294
Filed 2022-11-29 23:04
Tx date 2022-11-25
$XRTX
XORTX Therapeutics Inc.
Keshri, Amar Deep
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
51,294
Filed 2022-11-25 23:23
Tx date 2022-11-11
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,920
+1,500 vol
$1.28 each
448,417
Filed 2022-11-25 23:22
Tx date 2022-11-11
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$126.00
+100 vol
$1.26 each
446,917
Filed 2022-11-25 23:22
Tx date 2022-11-11
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$375.00
+300 vol
$1.25 each
446,817
Filed 2022-11-25 23:21
Tx date 2022-11-11
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,364
+1,100 vol
$1.24 each
446,517
Filed 2022-11-25 23:20
Tx date 2022-11-11
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,690
+3,000 vol
$1.23 each
445,417
Filed 2022-11-25 23:19
Tx date 2022-11-11
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,220
+1,000 vol
$1.22 each
442,417
Filed 2022-11-25 23:18
Tx date 2022-11-11
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$600.00
+500 vol
$1.20 each
441,417
Filed 2022-11-25 23:14
Tx date 2022-11-11
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,570
+3,000 vol
$1.19 each
440,917
Filed 2022-10-21 23:51
Tx date 2022-10-19
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$665.00
+500 vol
$1.33 each
437,917
Filed 2022-10-21 23:50
Tx date 2022-10-19
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,244
+1,700 vol
$1.32 each
437,417
Filed 2022-10-21 23:49
Tx date 2022-10-19
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$393.00
+300 vol
$1.31 each
435,717
Filed 2022-10-21 23:49
Tx date 2022-10-17
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,360
+2,000 vol
$1.18 each
435,417
Filed 2022-10-21 23:48
Tx date 2022-10-17
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$600.00
+500 vol
$1.20 each
433,417
Filed 2022-06-24 16:46
Tx date 2022-06-24
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,629
+1,000 vol
$1.63 each
432,917
Filed 2022-06-24 16:46
Tx date 2022-06-22
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,600
+1,000 vol
$1.60 each
431,917
Filed 2022-06-23 13:00
Tx date 2022-06-06
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
Filed 2022-06-09 22:42
Tx date 2022-06-06
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
Filed 2022-06-10 14:12
Tx date 2022-06-03
$XRTX
XORTX Therapeutics Inc.
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$240,000
+150,000 vol
$1.60 each
150,000
Filed 2022-06-10 14:09
Tx date 2022-06-03
$XRTX
XORTX Therapeutics Inc.
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-06-09 22:59
Tx date 2022-06-06
$XRTX
XORTX Therapeutics Inc.
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+94,822 vol
200,000
Filed 2022-06-09 22:57
Tx date 2022-06-06
$XRTX
XORTX Therapeutics Inc.
Le Saux, Jacqueline Henriette Raymonde
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
65,000
Filed 2022-06-09 22:54
Tx date 2022-06-06
$XRTX
XORTX Therapeutics Inc.
Farley, William James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
65,000
Filed 2022-06-09 22:52
Tx date 2022-06-06
$XRTX
XORTX Therapeutics Inc.
Pratt, Raymond
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
60,000
Filed 2022-06-09 22:42
Tx date 2022-06-06
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
120,000
Filed 2022-06-08 18:24
Tx date 2022-06-06
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$48,000
+30,000 vol
$1.60 each
90,000
Filed 2022-06-08 17:57
Tx date 2021-09-24
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-686,291 vol
63,993
Filed 2021-10-06 10:52
Tx date 2021-09-24
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-686,376 vol
Filed 2022-06-06 11:16
Tx date 2022-06-06
$XRTX
XORTX Therapeutics Inc.
Klassen, Ian McCulloch
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$48,000
+30,000 vol
$1.60 each
80,000